Global X HealthTech ETF (NASDAQ:HEAL) Sees Significant Decline in Short Interest

Posted by Alanna Baker on Feb 26th, 2026

Global X HealthTech ETF (NASDAQ:HEAL – Get Free Report) was the recipient of a large decline in short interest in the month of February. As of February 13th, there was short interest totaling 1,547 shares, a decline of 74.3% from the January 29th total of 6,028 shares. Currently, 0.1% of the company’s shares are sold short. Based on an average daily volume of 19,205 shares, the short-interest ratio is currently 0.1 days. Based on an average daily volume of 19,205 shares, the short-interest ratio is currently 0.1 days. Currently, 0.1% of the company’s shares are sold short.

Global X HealthTech ETF Stock Up 1.5%

HEAL stock opened at $26.40 on Thursday. The firm has a market cap of $35.11 million, a price-to-earnings ratio of 42.80 and a beta of 1.13. The company’s fifty day simple moving average is $28.75 and its 200 day simple moving average is $30.58. Global X HealthTech ETF has a 12-month low of $24.48 and a 12-month high of $34.20.

Global X HealthTech ETF Dividend Announcement

The firm also recently declared a dividend, which was paid on Wednesday, January 7th. Shareholders of record on Tuesday, December 30th were issued a dividend of $0.0718 per share. The ex-dividend date was Tuesday, December 30th.

Institutional Investors Weigh In On Global X HealthTech ETF

Large investors have recently bought and sold shares of the stock. AE Wealth Management LLC bought a new stake in Global X HealthTech ETF in the third quarter valued at $34,000. Banque Cantonale Vaudoise bought a new stake in Global X HealthTech ETF in the 3rd quarter valued at about $37,000. Glenmede Investment Management LP bought a new stake in Global X HealthTech ETF in the 3rd quarter valued at about $31,000. Daiwa Securities Group Inc. acquired a new position in Global X HealthTech ETF during the 3rd quarter worth approximately $11,239,000. Finally, Raymond James Financial Inc. bought a new position in Global X HealthTech ETF in the third quarter worth approximately $274,000.

About Global X HealthTech ETF

(Get Free Report)

An ETF that invests in companies at the intersection of healthcare and technology, targeting innovations in drug discovery, medical devices, consumer healthcare, and analytics.